Symmetry Peak Management LLC Bio N Tech Se Transaction History
Symmetry Peak Management LLC
- $91.4 Million
- Q4 2024
A detailed history of Symmetry Peak Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Symmetry Peak Management LLC holds 3,500 shares of BNTX stock, worth $318,710. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,500Holding current value
$318,710% of portfolio
0.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
365Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$749 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$401 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$391 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$173 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$165 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $22.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...